These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
295 related articles for article (PubMed ID: 17346112)
1. Regulatory aspects of oncolytic virus products. Yamaguchi T; Uchida E Curr Cancer Drug Targets; 2007 Mar; 7(2):203-8. PubMed ID: 17346112 [TBL] [Abstract][Full Text] [Related]
2. Oncolytic Virus: Regulatory Aspects from Quality Control to Clinical Studies. Yamaguchi T; Uchida E Curr Cancer Drug Targets; 2018; 18(2):202-208. PubMed ID: 28228083 [TBL] [Abstract][Full Text] [Related]
3. Meeting product development challenges in manufacturing clinical grade oncolytic adenoviruses. Working PK; Lin A; Borellini F Oncogene; 2005 Nov; 24(52):7792-801. PubMed ID: 16299538 [TBL] [Abstract][Full Text] [Related]
4. Oncolytic Virotherapy by HSV. Watanabe D; Goshima F Adv Exp Med Biol; 2018; 1045():63-84. PubMed ID: 29896663 [TBL] [Abstract][Full Text] [Related]
5. Recent advances in oncolytic virus-based cancer therapy. Fu LQ; Wang SB; Cai MH; Wang XJ; Chen JY; Tong XM; Chen XY; Mou XZ Virus Res; 2019 Sep; 270():197675. PubMed ID: 31351879 [TBL] [Abstract][Full Text] [Related]
6. Oncolytic virotherapy for oral squamous cell carcinoma using replication-competent viruses. Saito K; Shirasawa H; Isegawa N; Shiiba M; Uzawa K; Tanzawa H Oral Oncol; 2009 Dec; 45(12):1021-7. PubMed ID: 19833547 [TBL] [Abstract][Full Text] [Related]
7. The use of the NIS reporter gene for optimizing oncolytic virotherapy. Miller A; Russell SJ Expert Opin Biol Ther; 2016; 16(1):15-32. PubMed ID: 26457362 [TBL] [Abstract][Full Text] [Related]
8. Oncolytic viruses in cancer therapy. Vähä-Koskela MJ; Heikkilä JE; Hinkkanen AE Cancer Lett; 2007 Sep; 254(2):178-216. PubMed ID: 17383089 [TBL] [Abstract][Full Text] [Related]
9. Oncorine, the World First Oncolytic Virus Medicine and its Update in China. Liang M Curr Cancer Drug Targets; 2018; 18(2):171-176. PubMed ID: 29189159 [TBL] [Abstract][Full Text] [Related]
10. Oncolytic virotherapy for cancer treatment: challenges and solutions. Davis JJ; Fang B J Gene Med; 2005 Nov; 7(11):1380-9. PubMed ID: 16025557 [TBL] [Abstract][Full Text] [Related]
11. A mathematical model of oncolytic virotherapy with time delay. Wang ZZ; Guo ZM; Smith H Math Biosci Eng; 2019 Mar; 16(4):1836-1860. PubMed ID: 31137188 [TBL] [Abstract][Full Text] [Related]
12. Cancer scene investigation: how a cold virus became a tumor killer. Post DE; Shim H; Toussaint-Smith E; Van Meir EG Future Oncol; 2005 Apr; 1(2):247-58. PubMed ID: 16555996 [TBL] [Abstract][Full Text] [Related]
13. The fourth front against cancer. The first clinical trials to test engineered viruses that attack tumour cells have yielded promising results for future cancer therapies. Hunter P EMBO Rep; 2011 Jul; 12(8):769-71. PubMed ID: 21799527 [No Abstract] [Full Text] [Related]
15. Advance in herpes simplex viruses for cancer therapy. Liu S; Dai M; You L; Zhao Y Sci China Life Sci; 2013 Apr; 56(4):298-305. PubMed ID: 23564184 [TBL] [Abstract][Full Text] [Related]
16. Clinical Application of Oncolytic Viruses: A Systematic Review. Cook M; Chauhan A Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33053757 [TBL] [Abstract][Full Text] [Related]
18. Editorial overview: Oncolytic viruses--replicating virus therapeutics for the treatment of cancer. Bell JC; McFadden G Curr Opin Virol; 2015 Aug; 13():viii-ix. PubMed ID: 26260227 [No Abstract] [Full Text] [Related]
19. Development of Group B Coxsackievirus as an Oncolytic Virus: Opportunities and Challenges. Liu H; Luo H Viruses; 2021 Jun; 13(6):. PubMed ID: 34198859 [TBL] [Abstract][Full Text] [Related]
20. Luciferase imaging for evaluation of oncolytic adenovirus replication in vivo. Guse K; Dias JD; Bauerschmitz GJ; Hakkarainen T; Aavik E; Ranki T; Pisto T; Särkioja M; Desmond RA; Kanerva A; Hemminki A Gene Ther; 2007 Jun; 14(11):902-11. PubMed ID: 17377596 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]